The interaction of CD44 and HA activates RhoA signals and Rho kinase, enhances serine/threonine phosphorylation on Gab-1 (Grb2-associated binder-1), induces PI3K activation, triggers the PI3K/Akt pathway, and is involved in the progression of breast cancer[28]. Here, AKT1 is linked to breast carcinoma.